Skip to the content
Kure Cellslogo darklogo light
  • Home
  • About Us
  • Technology
  • Pipeline
  • News
  • Partner With Us
Kure Cells
  • Home
  • About Us
  • Technology
  • Pipeline
  • News
  • Partner With Us
Home2025August
w
https://marity.qodeinteractive.com/wp-content/uploads/2022/11/Josh-Woodward-Gravity-1.mp3
KureCells

NCI $2.2 M Grant to support Phase 2 UF-Kure19 trial

rkjamvi@gmail.com
August 8, 2025
rkjamvi@gmail.com

principal scientist

Kure Cells closed pre-Series A funding round led by Waed Ventures (Aramco) alongside NantBio, US93 and Qomel

rkjamvi@gmail.com
October 23, 2025

UF-Kure19 granted RMAT designation by FDA based on promising efficacy for LBCL and follicular lymphoma and rapid manufacturing

rkjamvi@gmail.com
October 17, 2025
Categories
KureCells
Follow us
w
We believe in open projects
View more

Disclaimer: Investigational products; safety and efficacy not yet established.

Privacy Policy

Expanded Access Policy

© 2025 kurecells, All Rights Reserved

Back to top Drag